Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substances to Combat Opioid Epidemic, Reduce Robbery Incidents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/15/2017 | 07:51pm CEST

By a News Reporter-Staff News Editor at Drug Week -- CVS Pharmacy announced that it has implemented the use of time delay safes in more than 170 locations in the Cincinnati, Columbus and Dayton markets as well as nearby locations in central and southern Ohio and northern Kentucky. This step will help prevent pharmacy robbery incidents and combat the ongoing opioid epidemic by keeping controlled substance narcotic medications from being misused or abused. Controlled substance narcotic medications that are sought after by robbers, such as oxycodone and hydrocodone, will now be stored in time delay safes in every CVS Pharmacy location in these three markets (see also CVS Health).

Time delay safes help deter pharmacy robberies by electronically delaying the time it takes for pharmacy employees to be able to open the safe. Employees must enter a code to open the safe, which automatically triggers a wait time before the safe is electronically unlocked.

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes are displaying highly-visible signage to inform the public that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of pharmacy robbery incidents in the Columbus, Cincinnati and Dayton markets," said Alisa Ulrey, Area Vice President of CVS Pharmacy in Ohio. "We believe that time delay safes, combined with other security policies and procedures in place at our stores, will help drastically reduce these incidents and ensure that our stores remain a safe environment for shopping and filling prescriptions."

Montgomery County Sheriff Phil Plummer said, "Drug Abuse continues to be a substantial health and safety risk in Montgomery County. With overdose deaths in Montgomery County being at an historical high, I believe any efforts to control substance narcotic medications that are sought after by robbers, such as oxycodone & hydrocodone, is welcome. I applaud CVS Pharmacy for taking this proactive step to combat the opioid epidemic in Montgomery County and across Ohio."

CVS Health's commitment to preventing and addressing prescription drug abuse extends to community education, efforts to encourage safe disposal of unused medication and increasing access to the opioid overdose-reversal drug naloxone. The company's Pharmacists Teach program brings CVS Pharmacists to schools across the country to talk to students about the dangers of prescription drug abuse. More than 250,000 students across the country, including more than 10,000 in Ohio, have participated in the program.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. This program has collected more than 80 metric tons, or 175,000 pounds of unused prescriptions, keeping them out of medicine cabinets where they could be misused.

Additionally, CVS Health has worked with 41 states - including Ohio and Kentucky - to increase access to the opioid overdose-reversal drug naloxone, also known as Narcan. Patients can obtain this life-saving medication, which is a safe and effective antidote to opioid overdoses, without an individual prescription in these states.

Keywords for this news article include: CVS Health, Drug Abuse, Legal Issues.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
08/23 CVS HEALTH : 's Accordant Earns NCQA Disease Management Accreditation for 18 Con..
08/21 CVS HEALTH CORP (NYSE : CVS) Study Reveals 66% of Americans Believe That Flu Sho..
08/19 CVS HEALTH : Laguna City Council to consider CVS' appeal to move into Laguna Dru..
08/19 INSIDER TRADING ACTIVITY CVS HEALTH : CVS) – Director Sold 2,500 shares o..
08/18 CVS HEALTH : SMART Clinic heads into its second year
08/18 UNITEDHEALTH : Corporate News Blog - UnitedHealth Group Announces New Leadership..
08/17 CVS PHARMACY : Earns URAC Reaccreditation in Community Pharmacy
08/17 CONSIDER YOUR PURPOSE : PA and PharmD Students Receive Short White Coats
08/16 CVS HEALTH : Prom night at YMCA Camp Oakes
08/16 CVS HEALTH : Survey Reveals Two in Three Americans who plan to get a Flu Shot Be..
More news
News from SeekingAlpha
08/22 5 Cheapest Funds For Dividend Investors
08/21 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2017 Upda..
08/18 CVS Health Corporation 2017 Q2 - Results - Earnings Call Slides
08/18 This Bottoming Healthcare Stock Just Narrowed Its Guidance
08/17 TARGET REPORTS Q2 : Updating My Bullish Comments From Last Month
Financials ($)
Sales 2017 184 098 M
EBIT 2017 10 053 M
Net income 2017 5 304 M
Debt 2017 24 744 M
Yield 2017 2,54%
P/E ratio 2017 15,44
P/E ratio 2018 13,20
EV / Sales 2017 0,56x
EV / Sales 2018 0,54x
Capitalization 79 048 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 86,6 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-1.61%79 048
WALGREENS BOOTS ALLIANCE-1.79%86 977
EXPRESS SCRIPTS HOLDING CO-10.42%35 589
MCKESSON CORPORATION5.57%31 177
CARDINAL HEALTH INC-10.55%20 702
AMERISOURCEBERGEN CORP.1.33%17 360